Gevorg Tamamyan: 80 speakers and around 450 participants from 30 countries
Gevorg Tamamyan, Editor-in-chief of OncoDaily, shared a post on LinkedIn:
“80 speakers and around 450 participants from 30 countries! Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer! During the 3 days of the of the largest events on colorectal cancer physicians, scientists, leaders of societies and organizations, policy makers, patients and advocates were challenging the status quo in colorectal cancer! Thank you everyone who contributed, an amazing OncoDaily team for organizing, all the speakers and participants! Thank you very much our platinum sponsor – leading immuno-oncology biotech Agenus and their wonderful team!
In the following weeks we will summarize all the recommendations and will put them together. This is going to be a recurring event, so stay tuned for the next one.”
Narine Mnatsakanyan shared this post on LinkedIn, adding:
“Global Cancer Movement- Challenging the Status Quo in Colorectal Cancer.
One of the biggest oncology event worldwide embraced the key members of this discipline.
Challenges in CRC need to voice out and get maximum solution in favor of patients.”
Gevorg Tamamyan is the Editor-in-chief of OncoDaily, President-Elect of SIOP Asia Continental Branch and Pediatric Oncology East and Mediterranean (POEM) Group, and the CEO of the Immune Oncology Research Institute (IMMONC). He is the Chairman and Professor of the department of Haematology and Pediatric Oncology at Yerevan State Medical University.
He is a Co-Founder and Board Member of the Armenian Association of Hematology and Oncology, City of Smile Charitable Foundation, Co-Founder and Chairman of the Board of the Institute of Cancer and Crisis, the Former President of the Harvard Club of Armenia.
Further Reading:
Highlights from Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer – Day 1
Highlights from Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer – Day 2
Highlights from Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer – Day 3
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023